Our results suggesting the inhibition of CD26 could improve the engraftment profile of hUCB-MSCs both in vitro (Figure 3A) and in vivo (Figure 5C) implies that the migration into lung of MSCs might be relevant with clinical outcomes, at least in a mouse emphysema model. Here, DPP4 is linked to pulmonary emphysema.